Biochemical Diagnostics, founded in 1991, is a global leader in the manufacture of consolidated toxicology quality control solutions for clinical laboratories, medical examiners and pain management centers, providing third party external QC materials for Drugs of Abuse, hCG and Adulterant testing.
DETECTABUSE® , STAT-SKREEN®, and PREGNANCY-SKREEN™ product offerings help to increase laboratory efficiencies through consolidation, and simplification the QC process. Biochemical Diagnostics became part of LGC Clinical Diagnostics in 2023.
DETECTABUSE and STAT-SKREEN are class leading, third-party, test-consolidated DOA controls. With an extensive list of toxicology drugs included in the DETECTABUSE or STAT-SKREEN product offerings, quality, choice and flexibility is guaranteed. In 2015, Biochemical Diagnostics launched our oral fluid matrix for drug testing, expanding our offering to both Urine and Synthetic Oral Fluid for both screening and confirmation testing.